Skip to main content
. 2017 Jun 9;66(22):579–583. doi: 10.15585/mmwr.mm6622a3

TABLE 2. Characteristics of Japanese encephalitis (JE) immunization programs in countries with JE virus transmission risk, 2016.

Country JE immunization program Strategy Scheduled age to begin routine immunization Vaccine used in national program
Australia*
All risk areas
Routine
12 mos
JE-CV
Bangladesh
None



Bhutan
None



Brunei
None



Cambodia
National
Routine
9 mos
CD-JEV
Burma
None§



China
National
Routine
8 mos
CD-JEV
Taiwan
All areas
Routine
15 mos
MB
India
Subnational**
Routine
9–11 mos
CD-JEV
Indonesia
None††



Japan
National
Routine
6 mos
VC
Laos
National
Routine
9–11 mos
CD-JEV
Malaysia
Subnational§§
Routine
9 mos
JE-CV
Nepal
National
Routine
12 mos
CD-JEV
North Korea
None¶¶



Pakistan
None



Papua New Guinea
None



Philippines
None***



Russia*
None



Singapore
None†††



South Korea
National
Routine
12 mos
CD-JEV, MB, VC,
Sri Lanka
National
Routine
12 mos
CD-JEV
Thailand
National
Routine
12 mos
CD-JEV, JE-CV
Timor Leste
None



Vietnam National Routine 12 mos MB

Abbreviations: CD-JEV = live attenuated JE vaccine; JE-CV = live recombinant JE vaccine; MB = inactivated, mouse brain-derived JE vaccine; VC = inactivated, Vero cell culture–derived JE vaccine.

* JE virus transmission risk in well-defined, limited areas.

Vaccination recommended for residents of the outer Torres Strait Islands or nonresidents living or working there for ≥30 days during the wet season.

§ Burma is planning a national JE vaccination campaign for 2017, followed by routine introduction.

Excluding the provinces of Qinghai, Tibet, and Xinjiang, which do not have endemic transmission.

** JE vaccine included in 216 districts with endemic JE.

†† Indonesia will initiate JE vaccine campaign in Bali in 2017.

§§ In Sarawak state; in peninsular Malaysia and Sabah, vaccination is provided to children aged <15 years in the vicinity of an outbreak.

¶¶ North Korea conducted a JE vaccination campaign in 2016.

*** Philippines is planning a subnational JE vaccination campaign in 2018, followed by routine introduction nationally.

††† Singapore made a decision not to introduce JE vaccine because only rare, sporadic human cases are reported in the country.